Literature DB >> 23054642

Cerebriform variant type of T cell prolymphocytic leukemia with complex karyotype including an additional segment at 1p36.1.

Senji Kasahara1, Hisashi Tsurumi, Yuhei Shibata, Takuro Matsumoto, Nobuhiko Nakamura, Hiroshi Nakamura, Nobuhiro Kanemura, Naoe Goto, Takeshi Hara, Hisataka Moriwaki.   

Abstract

We describe two patients with T cell prolymphocytic leukemia (T-PLL) who exhibited the same complex karyotype, including an additional segment at 1p36.1. One presented with secondary progression following an initial stable clinical course, and the other with typically progressive disease. Features of the cerebriform variant were identified in the peripheral blood of both patients. Aggressive symptoms, such as lymphocytosis, lymphadenopathy, pleural effusion, cutaneous involvement and hepatosplenomegaly, developed during the progressive phases. Levels of serum soluble interleukin 2 receptor increased when symptoms worsened. These patients did not have the karyotypic 14q11 abnormality and trisomy 8q that are features of non-Japanese patients. The prognoses of these patients were poor; one survived for 2 months and the other survived for 10 months after progression. A chromosomal abnormality may occur in other types of aggressive T-PLL, particularly when extramedullary infiltration is a feature.

Entities:  

Mesh:

Year:  2012        PMID: 23054642     DOI: 10.1007/s12185-012-1176-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  15 in total

1.  Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance.

Authors:  T Koski; R Karhu; T Visakorpi; L Vilpo; S Knuutila; J Vilpo
Journal:  Eur J Haematol       Date:  2000-07       Impact factor: 2.997

2.  Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia?

Authors:  R Pawson; E Matutes; V Brito-Babapulle; H Maljaie; M Hedges; J Mercieca; M Dyer; D Catovsky
Journal:  Leukemia       Date:  1997-07       Impact factor: 11.528

3.  Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia.

Authors:  E Matutes; V Brito-Babapulle; J Swansbury; J Ellis; R Morilla; C Dearden; A Sempere; D Catovsky
Journal:  Blood       Date:  1991-12-15       Impact factor: 22.113

4.  Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Français d'Hématologie Cellulaire.

Authors:  R Garand; J Goasguen; A Brizard; J Buisine; A Charpentier; J F Claisse; E Duchayne; M Lagrange; C Segonds; X Troussard; G Flandrin
Journal:  Br J Haematol       Date:  1998-11       Impact factor: 6.998

5.  International scoring system for evaluating prognosis in myelodysplastic syndromes.

Authors:  P Greenberg; C Cox; M M LeBeau; P Fenaux; P Morel; G Sanz; M Sanz; T Vallespi; T Hamblin; D Oscier; K Ohyashiki; K Toyama; C Aul; G Mufti; J Bennett
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

6.  The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists.

Authors: 
Journal:  Pathol Int       Date:  2000-09       Impact factor: 2.534

7.  High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.

Authors:  Marco Herling; Kaushali A Patel; Michael A Teitell; Marina Konopleva; Farhad Ravandi; Ryuji Kobayashi; Dan Jones
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

Review 8.  Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper.

Authors:  M Dungarwalla; E Matutes; C E Dearden
Journal:  Eur J Haematol       Date:  2008-03-10       Impact factor: 2.997

9.  Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma.

Authors:  J Dien Bard; P Gelebart; M Anand; H M Amin; R Lai
Journal:  Leukemia       Date:  2008-05-29       Impact factor: 11.528

10.  TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia.

Authors:  M G Narducci; L Virgilio; M Isobe; A Stoppacciaro; R Elli; M Fiorilli; M Carbonari; A Antonelli; L Chessa; C M Croce; G Russo
Journal:  Blood       Date:  1995-09-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.